Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Horbinski

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Surgical Pathology Clinics|March 6, 2013
Something old and something new about molecular diagnostics in gliomasCraig Horbinski
Acta Neuropathologica|March 21, 2013
What do we know about IDH1/2 mutations so far, and how do we use it?Craig Horbinski
Seminars in Diagnostic Pathology|September 24, 2010
Practical molecular diagnostics in neuropathology: making a tough job a little easierCraig Horbinski
Journal of Neuropathology and Experimental Neurology|December 18, 2012
To BRAF or not to BRAF: is that even a question anymore?Craig Horbinski
Neuro-Oncology|November 17, 2018
Differences in molecular profiles of glioblastomas according to locationCraig Horbinski
Neuro-Oncology|January 22, 2015
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative gliomaCraig Horbinski
Journal of Hematology & Oncology|July 16, 2020
Beyond thrombosis: the impact of tissue factor signaling in cancerDusten Unruh, Craig Horbinski
Brain Pathology (Zurich, Switzerland)|August 13, 2013
A 29 year old woman with acute mental status changesJanna Neltner, Craig Horbinski
Neuro-Oncology|August 14, 2020
Mesenchymal stemlike cells in glioblastomaAnh Nhat Tran, Craig Horbinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2023
Glioma Response to IDH Inhibition: Real-World ExperienceRimas V Lukas, Craig Horbinski
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Surgical Pathology Clinics|March 6, 2013
Something old and something new about molecular diagnostics in gliomasCraig Horbinski
Acta Neuropathologica|March 21, 2013
What do we know about IDH1/2 mutations so far, and how do we use it?Craig Horbinski
Seminars in Diagnostic Pathology|September 24, 2010
Practical molecular diagnostics in neuropathology: making a tough job a little easierCraig Horbinski
Journal of Neuropathology and Experimental Neurology|December 18, 2012
To BRAF or not to BRAF: is that even a question anymore?Craig Horbinski
Neuro-Oncology|November 17, 2018
Differences in molecular profiles of glioblastomas according to locationCraig Horbinski
Neuro-Oncology|January 22, 2015
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative gliomaCraig Horbinski
Journal of Hematology & Oncology|July 16, 2020
Beyond thrombosis: the impact of tissue factor signaling in cancerDusten Unruh, Craig Horbinski
Brain Pathology (Zurich, Switzerland)|August 13, 2013
A 29 year old woman with acute mental status changesJanna Neltner, Craig Horbinski
Neuro-Oncology|August 14, 2020
Mesenchymal stemlike cells in glioblastomaAnh Nhat Tran, Craig Horbinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2023
Glioma Response to IDH Inhibition: Real-World ExperienceRimas V Lukas, Craig Horbinski
Pageof 21